Gainers Equillium, Inc. (NASDAQ: EQ) shares surged 730.7% to close at $26.50 on Monday after the company disclosed that Itolizumab significantly reduced mortality in coronavirus patients, according to a clinical trial conducted in India by its partner Biocon.
Benzinga · 07/14 09:11
AirNet Announces Receipt of Deficiency Letter from Nasdaq
PR Newswire · 07/06 11:00
AirNet Announces Receipt of Deficiency Letter from Nasdaq Due to Failure to File its Annual Report on a Timely Basis
Benzinga · 07/06 10:16
WORK, PD among premarket losers
Seeking Alpha - Article · 06/05 13:21
Stocks That Hit 52-Week Lows On Friday
On Friday, 14 companies hit new 52-week lows.
Benzinga · 05/15 15:04
AirNet announces notice from Nasdaq on tolling of minimum bid price compliance period
Seeking Alpha - Article · 04/21 16:18
AirNet Announces Receipt of Notice From Nasdaq on Tolling of Minimum Bid Price Compliance Period
PR Newswire · 04/21 12:00
AirNet Announces Receipt of Minimum Bid Price Notice From NASDAQ